Acro Biomedical Co., Ltd.
ACBM· OTC
Quarterly figures for Acro Biomedical Co., Ltd., with source filings when available.
42 quarters. Mar 31, 2015 to Jun 30, 2026. USD.
Acro Biomedical Co., Ltd. has filed its 10-Q within 35 to 124 days of period end across its last 8 quarters. The 10-K runs 42 to 108 days.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $0.00 | — | $0.00 | |
| Q1 2026 | Mar 31, 2026 | — | May 5, 2026 | 35 d | 10-Q | $0.00 | — | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Feb 11, 2026 | 42 d | 10-K | $0.00 | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 10, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Jul 24, 2025 | 205 d | 10-K | $0.00 | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Jul 23, 2025 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Jul 18, 2025 | 565 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2023 | Sep 30, 2023 | — | Jul 11, 2025 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Jul 21, 2023 | 202 d | 10-K | $360.00K | −39.8% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 21, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Apr 15, 2022 | 105 d | 10-K | $598.00K | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 22, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Apr 2, 2021 | 92 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 17, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019 | Dec 31, 2019 | — | — | — | — | $193.54K | −85.7% | $0.00 | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $0.00 | — | $0.00 | |
| Q2 2019 | |||||||||
| FY 2018 | |||||||||
| Q4 2018 | Dec 31, 2018 | — | — | — | — | $1.35M | — | $0.00 | |
| FY 2017 | |||||||||
| Q4 2017derived | Sep 30, 2017 | — | Jan 16, 2018 | 108 d | 10-K | — | — | — | |
| Q3 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | ||||
| FY 2016 | |||||||||
| Q4 2016derived | Sep 30, 2016 | — | Dec 16, 2016 | 77 d | 10-K | — | — | — | |
| Q3 2016 | Jun 30, 2016 | — | Aug 3, 2016 | 34 d | 10-Q | ||||
| FY 2015 | |||||||||
| Q4 2015derived | Sep 30, 2015 | — | — | — | — | — | — | — | |
| Q3 2015 | Jun 30, 2015 | — | — | — | — | — | — | $0.00 | |
| Q2 2015 | |||||||||
| 41 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2025 | Jun 30, 2025 | — | Aug 5, 2025 | 36 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2025 | Mar 31, 2025 | — | Jul 24, 2025 | 115 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 296 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2024 | Jun 30, 2024 | — | Jul 23, 2025 | 388 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2024 | Mar 31, 2024 | — | Jul 22, 2025 | 478 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 650 d |
| 10-Q |
| $0.00 |
| — |
| -$0.03 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $0.00 | — | -$0.05 |
|---|
| Q1 2023 | Mar 31, 2023 | — | Aug 2, 2023 | 124 d | 10-Q | $0.00 | −100.0% | -$0.07 |
|---|
| 52 d |
| 10-Q |
| $0.00 |
| — |
| -$0.07 |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | $0.00 | −100.0% | — |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | $298.50K | +200.0% | — |
|---|
| 53 d |
| 10-Q |
| $0.00 |
| — |
| -$0.05 |
| Q2 2021 | Jun 30, 2021 | — | Aug 23, 2021 | 54 d | 10-Q | $500.00K | — | -$0.02 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 24, 2021 | 54 d | 10-Q | $99.50K | −85.5% | $0.00 |
|---|
| 48 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2020 | Jun 30, 2020 | — | Aug 19, 2020 | 50 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 19, 2020 | 49 d | 10-Q | $687.96K | — | $0.00 |
|---|
| Jun 30, 2019 |
| — |
| Aug 14, 2019 |
| 45 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q1 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | $0.00 | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2017 | Mar 31, 2017 | — | May 22, 2017 | 52 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2017 | Dec 31, 2016 | — | Feb 14, 2017 | 45 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2016 | Mar 31, 2016 | — | May 13, 2016 | 43 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2016 | Dec 31, 2015 | — | — | — | — | — | — | $0.00 |
|---|
| Mar 31, 2015 |
| — |
| — |
| — |
| — |
| — |
| — |
| $0.00 |